SAM
Sectoral Asset Management Portfolio holdings
AUM
$125M
1-Year Est. Return
68.15%
This Fund
S&P 500
1 Year Est. Return
+68.15%
AUM
$162M
AUM Growth
+$10.6M
(+7%)
Holding
98
Top Buys
| 1 | +$6.01M | |
| 2 | +$3.4M | |
| 3 | +$3.06M | |
| 4 |
AnaptysBio
ANAB
|
+$2.54M |
| 5 |
TECX
Tectonic Therapeutic
TECX
|
+$1.94M |
Top Sells
| 1 | +$28.6M | |
| 2 | +$7.54M | |
| 3 | +$2.43M | |
| 4 |
Replimune Group
REPL
|
+$2.15M |
| 5 |
PVLA
Palvella Therapeutics
PVLA
|
+$2.07M |
Sector Composition
| 1 | Healthcare | 97.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
26
BeOne Medicines Ltd
ONC
$32.3B
| $2.45M | 1.51% |
7,201
-515
|
|
||
27
Abbott
ABT
$193B
| $2.3M | 1.42% |
17,198
+2,000
|
|
||
28
Regeneron Pharmaceuticals
REGN
$81.2B
| $2.23M | 1.38% |
3,968
+1,195
|
|
||
29
Gilead Sciences
GILD
$180B
| $2.17M | 1.34% |
19,550
-140
|
|
||
30
Boston Scientific
BSX
$107B
| $2.16M | 1.33% |
22,126
+1,000
|
|
||
31
Danaher
DHR
$143B
| $2.1M | 1.3% |
10,575
|
|
||
32
Pfizer
PFE
$151B
| $1.97M | 1.21% |
77,150
|
|
||
33
Insmed
INSM
$31B
| $1.93M | 1.19% |
13,425
-1,455
|
|
||
34
Thermo Fisher Scientific
TMO
$195B
| $1.89M | 1.17% |
3,900
|
|
||
35
uniQure
QURE
$663M
| $1.79M | 1.11% |
30,740
-24,710
|
|
||
36
BioNTech
BNTX
$25.3B
| $1.74M | 1.08% |
17,660
+1,500
|
|
||
37
Stryker
SYK
$141B
| $1.59M | 0.98% |
4,300
+400
|
|
||
38
Summit Therapeutics
SMMT
$11.6B
| $1.53M | 0.94% |
74,070
+8,850
|
|
||
39
Alnylam Pharmaceuticals
ALNY
$42.7B
| $1.49M | 0.92% |
3,273
-50
|
|
||
40
AstraZeneca
AZN
$306B
| $1.44M | 0.89% |
18,750
+110
|
|
||
41
DexCom
DXCM
$27.3B
| $1.39M | 0.86% |
20,700
+7,500
|
|
||
42
Merck
MRK
$287B
| $1.39M | 0.86% |
16,400
-4,500
|
|
||
43
BioMarin Pharmaceuticals
BMRN
$11.6B
| $1.36M | 0.84% |
25,030
+1,500
|
|
||
|
RAPP
44
Rapport Therapeutics
RAPP
$1.4B
| $1.29M | 0.8% |
43,480
-136,380
|
|
||
45
Mineralys Therapeutics
MLYS
$2.15B
| $1.28M | 0.79% |
33,885
-348,530
|
|
||
46
Syndax Pharmaceuticals
SNDX
$1.86B
| $1.22M | 0.75% |
79,430
+16,130
|
|
||
47
Edwards Lifesciences
EW
$48.4B
| $1.17M | 0.72% |
15,000
|
|
||
48
Tarsus Pharmaceuticals
TARS
$3.2B
| $1.09M | 0.68% |
18,405
-130
|
|
||
|
MRUS
49
DELISTED
Merus
MRUS
| $1.09M | 0.67% |
11,545
-4,130
|
|
||
50
Trevi Therapeutics
TRVI
$1.67B
| $969K | 0.6% |
105,950
-28,200
|
|